NCT06861777 2025-03-11Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCCCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2/3 Not yet recruiting474 enrolled